निर्यात तैयार है — 
लोड हो रहा है...

Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries

BACKGROUND: Hepatitis C virus (HCV) infection is the leading cause of cirrhosis, end-stage liver disease and hepatocellular carcinoma (HCC) worldwide. In Europe, people who inject drugs (PWID) represent the majority of HCV infections, but are often excluded from treatment. The aim of this study was...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Harm Reduct J
मुख्य लेखकों: Maticic, Mojca, Zorman, Jerneja Videcnik, Gregorcic, Sergeja, Schatz, Eberhard, Lazarus, Jeffrey V.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2019
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509821/
https://ncbi.nlm.nih.gov/pubmed/31072401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12954-019-0303-9
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!